Abbott Nutrition Sales Decline but Show Sequential Improvement

Dow Jones
07/16

Abbott's Nutrition segment reported a 3.1% sales decline in the second quarter, with comparable sales down 3.6%. The company attributes the drop to lower sales volumes compared to the prior year and strategic pricing actions implemented in the fourth quarter of 2025. U.S. Pediatric Nutrition fell 10.7%, while international pediatric sales rose 7.3%. There's a sequential uptick, however: Nutrition sales increased $127 million from the first quarter of 2026. Abbott says the pricing actions and new product launches are contributing to improving performance

 

This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.

 

(END) Dow Jones Newswires

July 16, 2026 08:19 ET (12:19 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10